TGTX logo

TG Therapeutics (TGTX) Current Liabilities

Annual Current Liabilities

$53.72 M
+$519.00 K+0.98%

31 December 2023

TGTX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$125.11 M
+$16.45 M+15.14%

30 September 2024

TGTX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TGTX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.0%+116.9%
3 y3 years-38.6%+42.7%
5 y5 years+38.3%+56.0%

TGTX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-38.6%+1.0%at high+243.3%
5 y5 years-38.6%+38.3%at high+243.3%
alltimeall time-38.6%>+9999.0%at high>+9999.0%

TG Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$125.11 M(+15.1%)
June 2024
-
$108.66 M(+9.0%)
Mar 2024
-
$99.68 M(+85.6%)
Dec 2023
$53.72 M(+1.0%)
$53.72 M(-6.9%)
Sept 2023
-
$57.68 M(-20.6%)
June 2023
-
$72.67 M(+15.2%)
Mar 2023
-
$63.08 M(+18.6%)
Dec 2022
$53.20 M(-18.6%)
$53.20 M(+46.0%)
Sept 2022
-
$36.45 M(-15.9%)
June 2022
-
$43.33 M(-20.7%)
Mar 2022
-
$54.66 M(-16.4%)
Dec 2021
$65.38 M(-25.3%)
$65.38 M(-25.4%)
Sept 2021
-
$87.66 M(+0.1%)
June 2021
-
$87.55 M(-5.3%)
Mar 2021
-
$92.49 M(+5.6%)
Dec 2020
$87.55 M(+3.7%)
$87.55 M(+12.7%)
Sept 2020
-
$77.67 M(+15.0%)
June 2020
-
$67.54 M(+7.0%)
Mar 2020
-
$63.12 M(-25.3%)
Dec 2019
$84.45 M(+117.3%)
$84.45 M(+5.3%)
Sept 2019
-
$80.20 M(+43.3%)
June 2019
-
$55.97 M(-8.2%)
Mar 2019
-
$60.94 M(+56.8%)
Dec 2018
$38.85 M(+39.0%)
$38.85 M(-3.4%)
Sept 2018
-
$40.24 M(+8.9%)
June 2018
-
$36.94 M(+10.8%)
Mar 2018
-
$33.34 M(+19.3%)
Dec 2017
$27.96 M(+65.6%)
$27.96 M(+41.3%)
Sept 2017
-
$19.79 M(-4.7%)
June 2017
-
$20.76 M(+5.2%)
Mar 2017
-
$19.73 M(+16.9%)
Dec 2016
$16.88 M(+60.3%)
$16.88 M(-0.0%)
Sept 2016
-
$16.88 M(+19.6%)
June 2016
-
$14.12 M(+58.8%)
Mar 2016
-
$8.89 M(-15.5%)
Dec 2015
$10.53 M(+105.6%)
$10.53 M(+8.7%)
Sept 2015
-
$9.69 M(+5.2%)
June 2015
-
$9.21 M(-3.6%)
Mar 2015
-
$9.55 M(+86.5%)
Dec 2014
$5.12 M(-18.9%)
$5.12 M(-42.5%)
Sept 2014
-
$8.90 M(+241.5%)
June 2014
-
$2.61 M(+31.1%)
Mar 2014
-
$1.99 M(-68.5%)
Dec 2013
$6.32 M(+185.1%)
$6.32 M(+11.3%)
Sept 2013
-
$5.68 M(+63.8%)
June 2013
-
$3.47 M(+40.2%)
Mar 2013
-
$2.47 M(+11.6%)
Dec 2012
$2.22 M(+38.0%)
$2.22 M(-25.1%)
Sept 2012
-
$2.96 M(+25.9%)
June 2012
-
$2.35 M(+92.2%)
Mar 2012
-
$1.22 M(-23.9%)
Dec 2011
$1.61 M(-51.2%)
$1.61 M(+6.0%)
Sept 2011
-
$1.52 M(-59.9%)
June 2011
-
$3.78 M(+12.9%)
Mar 2011
-
$3.35 M(+1.8%)
Dec 2010
$3.29 M
$3.29 M(-21.7%)
Sept 2010
-
$4.21 M(-14.6%)
DateAnnualQuarterly
June 2010
-
$4.93 M(-31.6%)
Mar 2010
-
$7.20 M(+184.5%)
Dec 2009
$2.53 M(+70.4%)
$2.53 M(+58.4%)
Sept 2009
-
$1.60 M(-11.1%)
June 2009
-
$1.80 M(+81.0%)
Mar 2009
-
$993.10 K(-33.2%)
Dec 2008
$1.49 M(-20.6%)
$1.49 M(-26.2%)
Sept 2008
-
$2.01 M(+37.3%)
June 2008
-
$1.47 M(-17.9%)
Mar 2008
-
$1.79 M(-4.6%)
Dec 2007
$1.87 M(-3.7%)
$1.87 M(+4.5%)
Sept 2007
-
$1.79 M(-29.2%)
June 2007
-
$2.53 M(+15.4%)
Mar 2007
-
$2.19 M(+12.8%)
Dec 2006
$1.94 M(+16.7%)
$1.94 M(+37.4%)
Sept 2006
-
$1.41 M(-36.1%)
June 2006
-
$2.21 M(-1.4%)
Mar 2006
-
$2.25 M(+34.9%)
Dec 2005
$1.67 M(+39.3%)
$1.67 M(-7.9%)
Sept 2005
-
$1.81 M(+24.7%)
June 2005
-
$1.45 M(+14.2%)
Mar 2005
-
$1.27 M(+6.3%)
Dec 2004
$1.20 M(+23.8%)
$1.20 M(-18.9%)
Sept 2004
-
$1.47 M(+136.2%)
June 2004
-
$624.40 K(-17.6%)
Mar 2004
-
$757.80 K(-21.6%)
Dec 2003
$966.00 K(-10.8%)
$966.00 K(-23.7%)
Sept 2003
-
$1.27 M(+20.0%)
June 2003
-
$1.05 M(-0.8%)
Mar 2003
-
$1.06 M(-1.8%)
Dec 2002
$1.08 M(+113.0%)
$1.08 M(+115.0%)
Sept 2002
-
$503.90 K(+17.8%)
June 2002
-
$427.70 K(-11.8%)
Mar 2002
-
$484.70 K(-4.7%)
Dec 2001
$508.60 K(-75.6%)
$508.60 K(-32.0%)
Sept 2001
-
$748.40 K(+5.9%)
June 2001
-
$706.90 K(-9.3%)
Mar 2001
-
$779.20 K(-62.5%)
Dec 2000
$2.08 M(+316.1%)
$2.08 M(+95.9%)
Sept 2000
-
$1.06 M(+95.7%)
June 2000
-
$542.50 K(+9.4%)
Mar 2000
-
$495.90 K(-0.8%)
Dec 1999
$500.00 K(-28.6%)
$500.00 K(+150.0%)
Sept 1999
-
$200.00 K(-50.0%)
June 1999
-
$400.00 K(-33.3%)
Mar 1999
-
$600.00 K(-14.3%)
Dec 1998
$700.00 K(+75.0%)
$700.00 K(+16.7%)
Sept 1998
-
$600.00 K(0.0%)
June 1998
-
$600.00 K(+200.0%)
Mar 1998
-
$200.00 K(-50.0%)
Dec 1997
$400.00 K(+33.3%)
$400.00 K(+33.3%)
Sept 1997
-
$300.00 K(-25.0%)
June 1997
-
$400.00 K(+33.3%)
Mar 1997
-
$300.00 K(0.0%)
Dec 1996
$300.00 K
$300.00 K(0.0%)
Sept 1996
-
$300.00 K(-25.0%)
June 1996
-
$400.00 K

FAQ

  • What is TG Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for TG Therapeutics?
  • What is TG Therapeutics annual current liabilities year-on-year change?
  • What is TG Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for TG Therapeutics?
  • What is TG Therapeutics quarterly current liabilities year-on-year change?

What is TG Therapeutics annual total current liabilities?

The current annual current liabilities of TGTX is $53.72 M

What is the all time high annual current liabilities for TG Therapeutics?

TG Therapeutics all-time high annual total current liabilities is $87.55 M

What is TG Therapeutics annual current liabilities year-on-year change?

Over the past year, TGTX annual total current liabilities has changed by +$519.00 K (+0.98%)

What is TG Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of TGTX is $125.11 M

What is the all time high quarterly current liabilities for TG Therapeutics?

TG Therapeutics all-time high quarterly total current liabilities is $125.11 M

What is TG Therapeutics quarterly current liabilities year-on-year change?

Over the past year, TGTX quarterly total current liabilities has changed by +$67.44 M (+116.92%)